Clindamycin Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on 03/21/2023. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Sagent Pharmaceuticals
- Package NDC
- 25021-115-06
- Dosage Form
- Injection
- Presentation
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)
- Initial Posting
- 03/21/2023
- Revised Date
Reason
Discontinuation of the manufacture of the drug